Literature DB >> 6230486

Thermal activation of hexosaminidase A in a genetic compound with Tay-Sachs disease.

Y Ben-Yoseph, M S Baylerian, T Momoi, H L Nadler.   

Abstract

Increase in total hexosaminidase activity has been observed during heat treatment of serum and leukocyte specimens from a 1-year-old boy with cherry-red spot and severe and progressive mental and motor deterioration. The activity increased 40% in the first 40-70 min of incubation at 50 degrees C and pH 4.3, but declined thereafter and was only slightly above the initial activity in the final 2-3 h of incubation. Heat treatment of specimens from family members revealed very reduced rates of inactivation of hexosaminidase in the proband's father and some paternal relatives, whereas those of the mother and some maternal relatives were indistinguishable from those of Tay-Sachs carriers. Mixing experiments with enzyme preparations from the proband, normal controls and patients with Tay-Sachs disease resulted in additive values and did not support the possibility of inhibitor- or activator-related defect. Fractionation of heat-treated samples by ion exchange chromatography and electrophoresis, as well as examination of the separated fractions for their thermostability, have shown that hexosaminidase A is the activated component and hexosaminidases B, I1 and I2 are not affected. These findings suggest that the patient is a genetic compound and the apparent thermal activation is probably due to formation of hexosaminidase A from altered alpha-subunits produced by the paternal mutant alpha-allele and beta-subunits produced by the normal beta-alleles.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6230486     DOI: 10.1007/bf01800733

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  15 in total

1.  Tay-Sachs disease with altered beta-hexosaminidase B: a new variant?

Authors:  T Momoi; M Sudo; K Tanioka; Y Nakao
Journal:  Pediatr Res       Date:  1978-02       Impact factor: 3.756

Review 2.  The biochemical genetics of the hexosaminidase system in man.

Authors:  E Beutler
Journal:  Am J Hum Genet       Date:  1979-03       Impact factor: 11.025

3.  Specific determination of N-acetyl-beta-D-hexosaminidase isozymes A and B by radioimmunoassay and radial immunodiffusion.

Authors:  B Geiger; R Navon; Y Ben-Yoseph; R Arnon
Journal:  Eur J Biochem       Date:  1975-08-01

4.  Evidence for two dissimilar polypeptide chains in the beta 2 subunit of hexosaminidase.

Authors:  D J Mahuran; F Tsui; R A Gravel; J A Lowden
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

5.  Biosynthesis of lysosomal enzymes in fibroblasts. Synthesis as precursors of higher molecular weight.

Authors:  A Hasilik; E F Neufeld
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

6.  Tay-sachs disease. Detection of heterozygotes and homozygotes by serum hexosaminidase assay.

Authors:  J S O'Brien; S Okada; A Chen; D L Fillerup
Journal:  N Engl J Med       Date:  1970-07-02       Impact factor: 91.245

7.  AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.

Authors:  E Conzelmann; K Sandhoff
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

8.  Hexosaminidase isozyme in type O Gm2 gangliosidosis (Sandhoff-Jatzkewitz disease).

Authors:  E Beutler; W Kuhl; D Comings
Journal:  Am J Hum Genet       Date:  1975-09       Impact factor: 11.025

9.  Human beta-D-N-acetylhexosaminidases A and B: expression and linkage relationships in somatic cell hybrids.

Authors:  P A Lalley; M C Rattazzi; T B Shows
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

10.  Hereditary heat-labile hexosaminidase B: its implication for recognizing Tay-Sachs genotypes.

Authors:  R Navon; J Nutman; R Kopel; L Gaber; N Gadoth; B Goldman; M Nitzan
Journal:  Am J Hum Genet       Date:  1981-11       Impact factor: 11.025

View more
  5 in total

1.  Diagnosis and carrier detection of Tay-Sachs disease: direct determination of hexosaminidase A using 4-methylumbelliferyl derivatives of beta-N-acetylglucosamine-6-sulfate and beta-N-acetylgalactosamine-6-sulfate.

Authors:  Y Ben-Yoseph; J E Reid; B Shapiro; H L Nadler
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

2.  Altered molecular size of N-acetylglucosamine 1-phosphotransferase in I-cell disease and pseudo-Hurler polydystrophy.

Authors:  Y Ben-Yoseph; M Potier; D A Mitchell; B A Pack; S B Melançon; H L Nadler
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

3.  Molecular size of N-acetylglucosaminylphosphotransferase and alpha-N-acetylglucosaminyl phosphodiesterase as determined in situ in Golgi membranes by radiation inactivation.

Authors:  Y Ben-Yoseph; M Potier; B A Pack; D A Mitchell; S B Melançon; H L Nadler
Journal:  Biochem J       Date:  1986-05-01       Impact factor: 3.857

4.  Mucolipidoses II and III variants with normal N-acetylglucosamine 1-phosphotransferase activity toward alpha-methylmannoside are due to nonallelic mutations.

Authors:  Y Ben-Yoseph; D A Mitchell; R M Yager; J T Wei; T H Chen; L Y Shih
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

5.  Molybdenum cofactor biosynthesis in humans. Identification of two complementation groups of cofactor-deficient patients and preliminary characterization of a diffusible molybdopterin precursor.

Authors:  J L Johnson; M M Wuebbens; R Mandell; V E Shih
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.